Precision AQ Executive and Leadership Team

Carlos Delucca, the Chief Operating Officer at Precision AQ, manages the internal infrastructure and operational workflows that support global service delivery. Focusing on the seamless unification of various specialized brands, the Chief Operating Officer optimizes cross-functional collaboration to enhance efficiency across all departments. This role involves streamlining data-driven technology solutions and evidence generation processes to ensure consistent quality for life sciences clients. By implementing scalable operational systems, Carlos Delucca drives productivity and resource allocation across the entire enterprise. The Chief Operating Officer works closely with other executive leaders to translate strategic goals into actionable daily tasks. Through the oversight of internal processes, Delucca maintains the operational agility necessary to adapt to rapid changes in the healthcare market. This leadership function remains vital for sustaining the company's capacity to deliver complex medical communications and branding services on a global scale.

Jacob Graetz, the President at Precision AQ, provides executive oversight for the company's diverse portfolio of life science services and advisory functions. Leading the organization toward its mission of ensuring patient access to innovative therapies, the President defines the overarching corporate vision and market positioning. This role involves fostering relationships with key industry partners and investors to support long-term growth and stability. By championing the integration of specialized units like medical communications and investor relations, Jacob Graetz drives a unified approach to commercialization. The President collaborates with the executive team to identify new opportunities for service expansion and technological advancement. Through strategic decision-making, Graetz ensures that the firm remains at the forefront of the life sciences sector. This leadership role demands a comprehensive understanding of the global healthcare landscape, allowing the President to guide the company through complex market challenges while maintaining a steadfast commitment to excellence and patient-focused results.

Christine Brandi, the Engagement Solutions Chief of Staff at Precision AQ, coordinates the strategic execution of omnichannel marketing and patient engagement initiatives. Overseeing the alignment of medical education and patient insights, the Engagement Solutions Chief of Staff ensures that client programs effectively communicate the value of life-changing therapies. This role involves managing complex projects that bridge the gap between clinical evidence and market adoption. By facilitating communication between internal teams and external stakeholders, Christine Brandi drives the successful implementation of integrated brand strategies. The Engagement Solutions Chief of Staff monitors project performance metrics to guarantee that all deliverables meet the high standards required by the life sciences industry. Through meticulous planning and resource management, Brandi supports the expansion of the company's footprint in international markets. This leadership position requires constant focus on patient-centric outcomes, ensuring that every engagement solution directly contributes to the overall success of the client's product portfolio.

Alexander Lobo, the Managing Director at Precision AQ, directs high-level commercialization strategies for global life sciences partners. Overseeing the integration of diverse service lines, the Managing Director ensures that complex therapeutic products reach patients through optimized market access pathways. This leadership role involves aligning internal advisory teams with evolving regulatory landscapes to maximize product value across international markets. By architecting comprehensive launch frameworks, Alexander Lobo drives sustainable growth for the organization. The Managing Director maintains constant collaboration with the Board to refine long-term business objectives. Through rigorous analysis of market trends, Lobo secures competitive advantages for clients. This position requires deep expertise in pricing models and evidence-based communication, ensuring that every strategic initiative supports the broader mission of improving patient outcomes. Ultimately, Lobo fosters a culture of excellence that defines the firm's reputation in the life sciences sector.